FemmePharma Global Healthcare, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1996-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://femmepharma.com
An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia
Phase 2
Completed
- Conditions
- Moderate to Severe Cyclic Mastalgia
- First Posted Date
- 2010-04-16
- Last Posted Date
- 2011-10-26
- Lead Sponsor
- FemmePharma Global Healthcare, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT01105793
- Locations
- 🇺🇸
Women's Health Care, San Diego, California, United States
🇺🇸Horizons Clinical Research, Denver, Colorado, United States
🇺🇸Kentucky Medical Research Center, Lexington, Kentucky, United States
A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence
- First Posted Date
- 2008-09-09
- Last Posted Date
- 2009-10-15
- Lead Sponsor
- FemmePharma Global Healthcare, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT00749632
- Locations
- 🇺🇸
SNBL Clinical Pharmacology Center, Baltimore, Maryland, United States
🇺🇸Advanced Biomedical Research, Hackensack, New Jersey, United States
A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2010-05-27
- Lead Sponsor
- FemmePharma Global Healthcare, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT00744276
- Locations
- 🇺🇸
Columbus Center for Women's Health Research, Columbus, Ohio, United States
🇺🇸Palm Beach Research Center, West Palm Beach, Florida, United States
🇺🇸James A Simon, M.D., PC, Washington, District of Columbia, United States
© Copyright 2025. All Rights Reserved by MedPath